Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inflammation pathways in 366 breast cancer (BC) patients and 366 age-matched cancer-free controls: A prospective, nationwide, longitudinal URCC NCORP study Meeting Abstract
| Authors: | Janelsins, M. C.; Yao, S.; Mustian, K. M.; Peppone, L. J.; Heckler, C. E.; Esparaz, B.; Giguere, J. K.; Irwin, R.; Neilan, B.; Ahles, T.; Ambrosone, C. B.; Morrow, G. R. |
| Abstract Title: | Chemotherapy-related cognitive impairment (CRCI), and neurotransmitter signaling, longevity, and inflammation pathways in 366 breast cancer (BC) patients and 366 age-matched cancer-free controls: A prospective, nationwide, longitudinal URCC NCORP study |
| Meeting Title: | 51st Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 33 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2015 May 29-Jun 2 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2015-05-20 |
| Language: | English |
| ACCESSION: | WOS:000358036901992 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2015.33.15_suppl.9503 |
| Notes: | Meeting Abstract: 9503 -- Source: Wos |
